Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Florida Weight Loss MD vs Invyncible

Florida Weight Loss MD
Graded #329

Lower grade

vs+0.8999999999999986
Invyncible
Graded #303

Higher grade

The verdict

Invyncible takes it — 61/100 to 60.1/100, but only just.

Invyncible grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Invyncible is a Florida-based telehealth platform offering semaglutide and tirzepatide programs for weight management. Florida Weight Loss MD is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueInvyncible +4
51
55
Dose & formulationInvyncible +11
53
64
Clinical oversightFlorida Weight Loss MD +8
78
70
Labs & monitoringFlorida Weight Loss MD +10
62
52
FulfillmentFlorida Weight Loss MD +2
67
65
Contract termsInvyncible +14
47
61
Florida Weight Loss MD · left barInvyncible · right bar

The numbers

MetricFlorida Weight Loss MDInvyncible
WeighScore60.1/10061/100
GradeCC
Scorecard rank#329#303
SemaglutideNot disclosed$192/mo (0.5 mg dose, compounded)
TirzepatideNot disclosed$210/mo (compounded)
Coverage1 state40 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Florida Weight Loss MD

Graded #329 · C

Strengths

  • Physician-led (Dr. Sergey Terushkin, MD, FACS) with same-day telehealth visits statewide in Florida
  • Offers both compounded GLP-1 and brand Wegovy/Ozempic/Mounjaro/Zepbound when appropriate
  • Accepts most insurance or self-pay; consult $99 with $49 applied to the program

Where it loses points

  • Florida residents only — no service outside the state
  • Monthly medication pricing is not published; disclosed after evaluation
  • Single-clinic operation rather than a national telehealth platform
Invyncible

Graded #303 · C

Strengths

  • Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
  • Physical corporate address published (St. Petersburg, FL)
  • LegitScript verification seal displayed
  • No long-term commitment required
  • Offers both semaglutide and tirzepatide programs

Where it loses points

  • Pricing not disclosed on the public site — fully gated behind signup
  • Drug forms (compounded vs brand, injection vs oral) not disclosed
  • 503A vs 503B designation not specified
  • Pharmacy partner not named
  • States served not listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard